Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 1/2 1

Status

Recruiting 3Not yet recruiting 1

Sponsor Class

INDUSTRY 9OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 4

Conditions

Stomach Neoplasms 3Gastric Cancer Adenocarcinoma Metastatic 1

Interventions

Oxaliplatin 1004Fluorouracil 800Capecitabine 764Gemcitabine 650Leucovorin 559Irinotecan 537Bevacizumab 512Radiotherapy 460Cisplatin 440Drug Therapy 298Cetuximab 280Surgical Procedures, Operative 228Paclitaxel 228S 1 (combination) 217pembrolizumab 205Docetaxel 199130-nm albumin-bound paclitaxel 196Nivolumab 193sintilimab 191Radiosurgery 190lenvatinib 180Folfox protocol 179Sorafenib 178Albumin-Bound Paclitaxel 173apatinib 170tislelizumab 161camrelizumab 160Neoadjuvant Therapy 158Blood Specimen Collection 154durvalumab 148

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
OTHER × zolbetuximab × Gastrointestinal × Clear all
NCT06468280 2026-01-21

ROSETTE

Shanghai Zhongshan Hospital

Phase 2 Recruiting
84 enrolled
Gastrointestinal

Stomach Neoplasms

NCT06962137 2025-12-22

RAINSPOT

Universitaire Ziekenhuizen KU Leuven

Phase 2 Recruiting
100 enrolled
Gastrointestinal

Gastric Cancer Adenocarcinoma Metastatic

NCT06732856 2025-07-28

NEO-CLAUD

Asan Medical Center

Phase 1/2 Recruiting
57 enrolled
Gastrointestinal

Stomach Neoplasms

NCT06881017 2025-03-18

Establishment of Precision Targeted Therapy Strategies for Advanced Gastric Cancer Based on Novel Molecular Subtyping

China Medical University, China

Phase 2 Not yet recruiting
140 enrolled
Gastrointestinal

Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡